High circulating levels of soluble CD30 correlate with impaired delayed-type hypersensitivity responses in HIV-infected patients

AIDS. 1999 Nov 12;13(16):2308-9. doi: 10.1097/00002030-199911120-00017.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use
  • Drug Therapy, Combination
  • HIV Infections / blood
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Hypersensitivity, Delayed / blood
  • Hypersensitivity, Delayed / immunology*
  • Ki-1 Antigen / blood*
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / therapeutic use

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Ki-1 Antigen
  • Reverse Transcriptase Inhibitors